# Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish Avatars

Source: https://onco.cc/trials/nct06270017/  
OnCo record `nct06270017` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial in colorectal cancer, run by University Hospital, Linkoeping, now recruiting.

## Summary

Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish Avatars is a phase 1/2, interventional study registered as NCT06270017 by University Hospital, Linkoeping, with a registry enrolment figure of 300 participants, started 2022-01-10 and due to reach its primary completion in 2025-12-31. Interventions recorded: Chemotherapy drug. Conditions listed: Colon Cancer. Primary outcome: Tumour growth. Colorectal eligibility wording from the registry: "* Colon cancer planned for radical colon resection signed informed consent". Sites: Sweden. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: ZEBRA-COLON
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06270017
- Phase: 1/2
- Setting: Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer
- Sponsor: University Hospital, Linkoeping
- Enrolled: 300

## Sources

- ClinicalTrials.gov NCT06270017: https://clinicaltrials.gov/study/NCT06270017

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06270017.json